ZNF140
gene geneOn this page
Also known as pHZ-39
Summary
ZNF140 (zinc finger protein 140, HGNC:12925) is a protein-coding gene on chromosome 12q24.33, encoding Zinc finger protein 140 (P52738). May be involved in transcriptional regulation as a repressor.
Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and sequence-specific double-stranded DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7699 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_003440
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12925 |
| Approved symbol | ZNF140 |
| Name | zinc finger protein 140 |
| Location | 12q24.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | pHZ-39 |
| Ensembl gene | ENSG00000196387 |
| Ensembl biotype | protein_coding |
| OMIM | 604082 |
| Entrez | 7699 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 10 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000319849, ENST00000355557, ENST00000356456, ENST00000392041, ENST00000412146, ENST00000429434, ENST00000440550, ENST00000440984, ENST00000536790, ENST00000544426, ENST00000880216, ENST00000880217, ENST00000880218
RefSeq mRNA: 4 — MANE Select: NM_003440
NM_001300776, NM_001300777, NM_001300778, NM_003440
CCDS: CCDS73550, CCDS9282
Canonical transcript exons
ENST00000355557 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001359753 | 133080923 | 133081072 |
| ENSE00002321298 | 133105510 | 133107428 |
| ENSE00003493554 | 133081273 | 133081329 |
| ENSE00003718943 | 133083466 | 133083561 |
| ENSE00003741905 | 133083103 | 133083229 |
Expression profiles
Bgee: expression breadth ubiquitous, 259 present calls, max score 89.62.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.1837 / max 68.3181, expressed in 1770 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 128857 | 7.4004 | 1747 |
| 128856 | 1.7833 | 1174 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.62 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.46 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.06 | gold quality |
| cortical plate | UBERON:0005343 | 88.57 | gold quality |
| ventricular zone | UBERON:0003053 | 87.73 | gold quality |
| adenohypophysis | UBERON:0002196 | 87.40 | gold quality |
| right uterine tube | UBERON:0001302 | 86.84 | gold quality |
| left ovary | UBERON:0002119 | 86.37 | gold quality |
| body of pancreas | UBERON:0001150 | 86.27 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 86.22 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.20 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.09 | gold quality |
| thyroid gland | UBERON:0002046 | 86.03 | gold quality |
| pituitary gland | UBERON:0000007 | 85.88 | gold quality |
| right ovary | UBERON:0002118 | 85.73 | gold quality |
| adrenal tissue | UBERON:0018303 | 85.45 | gold quality |
| ovary | UBERON:0000992 | 85.42 | gold quality |
| islet of Langerhans | UBERON:0000006 | 85.18 | gold quality |
| pancreas | UBERON:0001264 | 84.90 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.79 | gold quality |
| body of uterus | UBERON:0009853 | 84.77 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.68 | gold quality |
| left uterine tube | UBERON:0001303 | 84.61 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.59 | gold quality |
| blood vessel layer | UBERON:0004797 | 84.59 | gold quality |
| oocyte | CL:0000023 | 84.16 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 84.12 | gold quality |
| right adrenal gland | UBERON:0001233 | 84.03 | gold quality |
| endocervix | UBERON:0000458 | 83.99 | gold quality |
| vagina | UBERON:0000996 | 83.98 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-110499 | no | 146.90 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| FCGR3B | Repression |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1589.1 | ZNF140 | More than 3 adjacent zinc fingers |
| MA1589.2 | ZNF140 | More than 3 adjacent zinc fingers |
| MA1589.3 | ZNF140 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28473536
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
78 targeting ZNF140, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 140 — P52738 (reviewed: P52738)
All UniProt accessions (8): P52738, F5GX08, F5H3Z2, F5H4I1, F5H644, F8WAF8, I3L0D9, I3L0I7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation as a repressor.
Subcellular location. Nucleus.
Tissue specificity. Seems ubiquitous. Seen in the heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P52738-1 | 1 | yes |
| P52738-2 | 2 |
RefSeq proteins (4): NP_001287705, NP_001287706, NP_001287707, NP_003431* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050527 |
Pfam: PF00096, PF01352, PF13912
UniProt features (15 total): zinc finger region 10, chain 1, domain 1, splice variant 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P52738-F1 | 68.78 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 90 (showing top):
DODD_NASOPHARYNGEAL_CARCINOMA_UP, chr12q24, WIKMAN_ASBESTOS_LUNG_CANCER_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, OKUMURA_INFLAMMATORY_RESPONSE_LPS, HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP, GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, LTE2_UP.V1_DN, MEK_UP.V1_DN, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, NFE2L1_TARGET_GENES
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (9): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
508 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF140 | LGALS4 | P56470 | 549 |
| ZNF140 | SNRNP35 | Q16560 | 507 |
| ZNF140 | EPHB2 | P29323 | 366 |
| ZNF140 | MSH6 | P52701 | 353 |
| ZNF140 | MSH3 | P20585 | 353 |
| ZNF140 | DHRS13 | Q6UX07 | 349 |
| ZNF140 | KANSL1L | A0AUZ9 | 348 |
| ZNF140 | TDRD10 | Q5VZ19 | 324 |
| ZNF140 | TLNRD1 | Q9H1K6 | 323 |
| ZNF140 | CCDC7 | Q96M83 | 320 |
| ZNF140 | XAGE2 | Q96GT9 | 315 |
| ZNF140 | E7ERQ6 | E7ERQ6 | 305 |
| ZNF140 | EPHB1 | P54762 | 303 |
| ZNF140 | NOC4L | Q9BVI4 | 296 |
| ZNF140 | ALKBH4 | Q9NXW9 | 288 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TEPSIN | AP4M1 | psi-mi:“MI:0914”(association) | 0.700 |
| CABP2 | ZNF140 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF140 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF140 | ARMC7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF140 | CABP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| WDR83 | SH2B2 | psi-mi:“MI:0914”(association) | 0.530 |
| CAND1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| WDR83 | PIKFYVE | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF140 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARMC7 | ZNF140 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): ZNF140 (Affinity Capture-MS), ZNF140 (Biochemical Activity), ZNF140 (Affinity Capture-MS), ZNF140 (Two-hybrid), ZNF140 (Two-hybrid), ZNF140 (Two-hybrid), ZNF140 (Affinity Capture-MS), ZNF140 (Affinity Capture-MS), ZNF140 (Affinity Capture-MS), HMGB1 (Cross-Linking-MS (XL-MS)), ZNF140 (Affinity Capture-MS), TRIM28 (Reconstituted Complex)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| ZNF140 | “down-regulates quantity by repression” | FCGR3B | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
906 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:133083101:AGG:A | acceptor_gain | 1.0000 |
| 12:133083102:GGG:G | acceptor_gain | 1.0000 |
| 12:133105508:A:AG | acceptor_gain | 1.0000 |
| 12:133105509:G:GG | acceptor_gain | 1.0000 |
| 12:133081069:T:G | donor_gain | 0.9900 |
| 12:133083537:G:T | donor_gain | 0.9900 |
| 12:133105506:TCA:T | acceptor_loss | 0.9900 |
| 12:133105508:A:C | acceptor_loss | 0.9900 |
| 12:133081033:A:T | donor_gain | 0.9800 |
| 12:133083097:TTTCA:T | acceptor_loss | 0.9800 |
| 12:133083098:TTCA:T | acceptor_loss | 0.9800 |
| 12:133083099:TCA:T | acceptor_loss | 0.9800 |
| 12:133083100:CA:C | acceptor_loss | 0.9800 |
| 12:133083101:A:G | acceptor_loss | 0.9800 |
| 12:133083102:G:GA | acceptor_loss | 0.9800 |
| 12:133083228:GG:G | donor_gain | 0.9800 |
| 12:133083229:GG:G | donor_gain | 0.9800 |
| 12:133083230:G:GA | donor_loss | 0.9800 |
| 12:133083231:TAA:T | donor_loss | 0.9800 |
| 12:133093503:GTT:G | donor_gain | 0.9800 |
| 12:133100973:A:G | acceptor_gain | 0.9800 |
| 12:133081045:A:T | donor_gain | 0.9700 |
| 12:133083101:A:AG | acceptor_gain | 0.9700 |
| 12:133083102:G:GG | acceptor_gain | 0.9700 |
| 12:133083225:ACTGG:A | donor_gain | 0.9700 |
| 12:133083227:TGG:T | donor_gain | 0.9700 |
| 12:133083228:GGG:G | donor_gain | 0.9700 |
| 12:133083230:G:GG | donor_gain | 0.9700 |
| 12:133083232:AAGTA:A | donor_loss | 0.9700 |
| 12:133081044:G:GT | donor_gain | 0.9600 |
AlphaMissense
3038 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:133106037:T:C | F254L | 0.997 |
| 12:133106039:T:A | F254L | 0.997 |
| 12:133106039:T:G | F254L | 0.997 |
| 12:133105869:T:C | F198L | 0.996 |
| 12:133105871:T:A | F198L | 0.996 |
| 12:133105871:T:G | F198L | 0.996 |
| 12:133106289:T:C | F338L | 0.996 |
| 12:133106291:C:A | F338L | 0.996 |
| 12:133106291:C:G | F338L | 0.996 |
| 12:133106457:T:C | F394L | 0.995 |
| 12:133106459:C:A | F394L | 0.995 |
| 12:133106459:C:G | F394L | 0.995 |
| 12:133106205:T:C | F310L | 0.994 |
| 12:133106207:T:A | F310L | 0.994 |
| 12:133106207:T:G | F310L | 0.994 |
| 12:133106541:T:C | F422L | 0.994 |
| 12:133106543:C:A | F422L | 0.994 |
| 12:133106543:C:G | F422L | 0.994 |
| 12:133105953:T:C | F226L | 0.993 |
| 12:133105955:C:A | F226L | 0.993 |
| 12:133105955:C:G | F226L | 0.993 |
| 12:133106121:T:C | F282L | 0.993 |
| 12:133106123:T:A | F282L | 0.993 |
| 12:133106123:T:G | F282L | 0.993 |
| 12:133106044:G:C | R256P | 0.992 |
| 12:133106056:T:C | L260P | 0.991 |
| 12:133106373:T:C | F366L | 0.991 |
| 12:133106375:C:A | F366L | 0.991 |
| 12:133106375:C:G | F366L | 0.991 |
| 12:133106140:T:C | L288P | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000150634 (12:133079992 A>G), RS1000182272 (12:133079679 C>T), RS1000189625 (12:133104237 A>G), RS1000261700 (12:133107249 A>T), RS1000314593 (12:133106947 C>A,T), RS1000332757 (12:133107629 C>T), RS1000499975 (12:133106968 A>G), RS1000504499 (12:133090819 A>C,G), RS1000514980 (12:133093827 T>A), RS1000535529 (12:133090790 A>C,G,T), RS1000572330 (12:133103378 T>A), RS1000672524 (12:133085859 A>T), RS1000867959 (12:133097686 C>T), RS1000937849 (12:133097517 C>G,T), RS1000977796 (12:133107272 A>G)
Disease associations
OMIM: gene MIM:604082 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005580_126 | Intraocular pressure | 4.000000e-08 |
| GCST010002_179 | Refractive error | 1.000000e-12 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004695 | intraocular pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 4 |
| Valproic Acid | affects expression, decreases expression, increases expression | 4 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| Particulate Matter | increases expression, decreases expression, increases abundance | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Asbestos | affects expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Oxazolone | increases expression | 1 |
| Oxygen | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW07 | HEK293 eGFP-ZNF140 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.